U.S. Organ-on-a-Chip Market (2025 - 2033) Size, Share & Trends Analysis Report By Product & Service, By Application (Drug Discovery, Toxicology Research), By End-use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Product & Service Segment
                        1.1.2. Application Segment
                        1.1.3. End Use Segment
                    1.2. Estimates and Forecast Timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Primary Research
                    1.5. Information or Data Analysis:
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                    1.8. List of Secondary Sources
                    1.9. List of Abbreviations
                    1.10. Objective
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Advancements in microfluidics & tissue engineering
                            3.2.1.2. Increasing demand for disease modeling technologies
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Technical challenges and complexities associated with organ-on-a-chip technique
                            3.2.2.2. Regulatory hurdles in organ-on-a-chip method
                    3.3. Industry Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
Chapter 4. Product & Service Group Business Analysis
                    4.1. Product & Service Segment Dashboard
                    4.2. U.S. Organ-on-a-Chip Market Product & Service Movement Analysis
                    4.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
                    4.4. Products
                        4.4.1. Products market estimates and forecasts, 2021 - 2033 (USD Million)
                        4.4.2. Instruments
                            4.4.2.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
                        4.4.3. U.S. Organ-on-a-Chip Devices
                            4.4.3.1. Organ-on-a-chip devices market estimates and forecasts, 2021 - 2033 (USD Million)
                            4.4.3.2. Liver-on-a-Chip
                                4.4.3.2.1. Liver-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
                            4.4.3.3. Lung-on-a-Chip
                                4.4.3.3.1. Lung-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
                            4.4.3.4. Intestine-on-a-Chip
                                4.4.3.4.1. Intestine-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
                            4.4.3.5. Kidney-on-a-Chip
                                4.4.3.5.1. Kidney-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
                            4.4.3.6. Heart-on-a-Chip
                                4.4.3.6.1. Heart-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
                            4.4.3.7. Others
                                4.4.3.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
                    4.5. Services
                        4.5.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Application Group Business Analysis
                    5.1. Application Segment Dashboard
                    5.2. U.S. Organ-on-a-Chip Market Application Movement Analysis
                    5.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    5.4. Drug Discovery
                        5.4.1. Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.5. Toxicology Research
                        5.5.1. Toxicology research market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.6. Others
                        5.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. End Use Business Analysis
                    6.1. End Use Segment Dashboard
                    6.2. U.S. Organ-on-a-Chip Market End Use Movement Analysis
                    6.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    6.4. Pharmaceutical & Biotechnology Companies
                        6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.5. Academic & Research Institute
                        6.5.1. Academic & research institute market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.6. Others
                        6.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Company Categorization
                    7.2. Strategy Mapping
                    7.3. Company Market Position Analysis, 2024
                    7.4. Company Profiles/Listing
                        7.4.1. Emulate, Inc.
                            7.4.1.1. Overview
                            7.4.1.2. Financial Performance
                            7.4.1.3. Product Benchmarking
                            7.4.1.4. Strategic Initiatives
                        7.4.2. MIMETAS B.V.
                            7.4.2.1. Overview
                            7.4.2.2. Financial Performance
                            7.4.2.3. Product Benchmarking
                            7.4.2.4. Strategic Initiatives
                        7.4.3. Valo Health
                            7.4.3.1. Overview
                            7.4.3.2. Financial Performance
                            7.4.3.3. Product Benchmarking
                            7.4.3.4. Strategic Initiatives
                        7.4.4. Quris Technologies LTD. (Nortis, Inc.)
                            7.4.4.1. Overview
                            7.4.4.2. Financial Performance
                            7.4.4.3. Product Benchmarking
                            7.4.4.4. Strategic Initiatives
                        7.4.5. AxoSim
                            7.4.5.1. Overview
                            7.4.5.2. Financial Performance
                            7.4.5.3. Product Benchmarking
                            7.4.5.4. Strategic Initiatives
                        7.4.6. BICO - THE BIO CONVERGENCE COMPANY
                            7.4.6.1. Overview
                            7.4.6.2. Financial Performance
                            7.4.6.3. Product Benchmarking
                            7.4.6.4. Strategic Initiatives
                        7.4.7. CN Bio Innovations Ltd
                            7.4.7.1. Overview
                            7.4.7.2. Financial Performance
                            7.4.7.3. Product Benchmarking
                            7.4.7.4. Strategic Initiatives
                        7.4.8. The Charles Stark Draper Laboratory, Inc.
                            7.4.8.1. Overview
                            7.4.8.2. Financial Performance
                            7.4.8.3. Product Benchmarking
                            7.4.8.4. Strategic Initiatives
                        7.4.9. SynVivo, Inc.
                            7.4.9.1. Overview
                            7.4.9.2. Financial Performance
                            7.4.9.3. Product Benchmarking
                            7.4.9.4. Strategic Initiatives
                        7.4.10. AlveoliX AG
                            7.4.10.1. Overview
                            7.4.10.2. Financial Performance
                            7.4.10.3. Product Benchmarking
                            7.4.10.4. Strategic Initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. organ-on-a-chip market, by product & service, 2021 - 2033 (USD Million)
Table 3. U.S. organ-on-a-chip market, by application, 2021 - 2033 (USD Million)
Table 4. U.S. organ-on-a-chip market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 U.S. Organ-on-a-chip market: market outlook
Fig. 7 U.S. Organ-on-a-chip competitive Insights
Fig. 8 Parent market outlook
Fig. 9 U.S. Organ-on-a-chip market driver impact
Fig. 10 U.S. Organ-on-a-chip market restraint impact
Fig. 11 U.S. Organ-on-a-chip market: Products & service movement analysis
Fig. 12 U.S. Organ-on-a-chip market: Products & service outlook and key takeaways
Fig. 13 Products market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 U.S. Organ-on-a-chip devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Liver-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 17 Lung-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 18 Intestine-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 Kidney-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Heart-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Services market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 23 U.S. Organ-on-a-chip market: Application movement analysis
Fig. 24 U.S. Organ-on-a-chip market: Application outlook and key takeaways
Fig. 25 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Toxicology research market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 U.S. Organ-on-a-chip market: End use movement analysis
Fig. 29 U.S. Organ-on-a-chip market: End use outlook and key takeaways
Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Academic & research institute market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Others market estimates and forecast, 2021 - 2033 (USD Million)